AML Video Channel
Explore the latest insights and summaries from experts in AML.
Diagnostics & Biomarkers
Rush University Medical Center
Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- 302 views
- May 29, 2024
- 4
Rush University Medical Center
What is New in AML: Risk Classification, Germline Mutations, and Targeted Therapies
FEATURING
Ehab Atallah
- 233 views
- May 29, 2024
- 1
Icahn School of Medicine at Mount Sinai
Navigating aGVHD Treatment: Integrating Recent Updates in Clinical Management
FEATURING
James Ferrara
- 52 views
- May 31, 2024
Vanderbilt University Medical Center (VUMC)
Prevention and Management of Post-SCT Relapse in Acute Leukemias
FEATURING
Andrew Jallouk
- 265 views
- July 18, 2024
- 6
Giuseppe Francesco Milone
Steroid-Refractory GvHD Management: When to Switch From Steroids
- 76 views
- August 1, 2024
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
AML: Diagnosis, Trends, and Approaches
FEATURING
Mary-Beth Percival
- 82 views
- August 14, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Approach to MRD Monitoring in AML: Assessing Treatment Efficacy and Relapse Risk
FEATURING
Tapan Kadia
- 108 views
- September 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradigm
FEATURING
Teresa Macarulla Mercade
- 55 views
- September 30, 2024
Rush University Medical Center
[duplicate] Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- May 29, 2024
SOHO Brazil 2024
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
FEATURING
Jeffrey Lancet
- 543 views
- July 11, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: AML
FEATURING
Farhad Ravandi
- 385 views
- March 25, 2024
- 2
Oncology Data Advisor
Navigating Hereditary Hematologic Malignancy Genetics
FEATURING
Sarah Bannon,
Hiam Abdel-Salam
- 26 views
- November 27, 2024